Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
Noted Medicine Specialist Professor Dr Md Billal Alam, Principal and head of the Department of Medicine, Sir Salimullah Medical College, Dhaka and President of Bangladesh Society of Medicine and Gynacologist Dr Feroza Wazed, Associate Professor, Dept. of Obstetrics and Gynacology, Dhaka Medical College and Hospital
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Gastab (Ranitidine) is a H2-receptor (histamine) antagonist. It is a competitive, reversible
inhibitor of the action of H2-receptors, on the parietal cells. As a result of its H2-receptor
blocking action, Gastab promotes rapid and effective ulcer healing with sustained pain
relief both day and night by a reduction of gastric acid output. After oral administration,
Ranitidine is rapidly absorbed from gastrointestinal tract. It is widely distributed
throughout the body and is 10-19% protein bound. It is metabolized in the liver and
excreted principally through urine.